COVID - 19 Vaccination Update - Day 476 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 40 Second

Posted On: 06 MAY 2022 8:11PM by PIB Delhi

India’s COVID-19 vaccination coverage has crossed 189.98 Crore (1,89,98,80,551) today. More than 15 lakh (15,44,728) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10405563
	2^nd Dose	10021937
	Precaution Dose	4901161
FLWs	1^st Dose	18416475
	2^nd Dose	17549279
	Precaution Dose	7862021
Age Group 12-14 years	1^st Dose	30170367
	2^nd Dose	9286031
Age Group 15-18 years	1^st Dose	58668750
	2^nd Dose	43022332
Age Group 18-44 years	1^st Dose	556029385
	2^nd Dose	480915785
	Precaution Dose	247284
Age Group 45-59 years	1^st Dose	202988332
	2^nd Dose	188639710
	Precaution Dose	745992
Over 60 years	1^st Dose	126916021
	2^nd Dose	117545172
	Precaution Dose	15548954
Cumulative 1^st dose administered		1003594893
Cumulative 2^nd dose administered		866980246
Precaution Dose		29305412
Total		1899880551

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 6^th April, 2022 (476^th Day)
HCWs	1^st Dose	47
	2^nd Dose	616
	Precaution Dose	16775
FLWs	1^st Dose	93
	2^nd Dose	1197
	Precaution Dose	49231
Age Group 12-14 years	1^st Dose	196773
	2^nd Dose	405957
Age Group 15-18 years	1^st Dose	37496
	2^nd Dose	110164
Age Group 18-44 years	1^st Dose	46916
	2^nd Dose	371972
	Precaution Dose	12525
Age Group 45-59 years	1^st Dose	10555
	2^nd Dose	88375
	Precaution Dose	28297
Over 60 years	1^st Dose	8343
	2^nd Dose	58317
	Precaution Dose	101079
Cumulative 1^st dose administered		300223
Cumulative 2^nd dose administered		1036598
Precaution Dose		207907
Total		1544728

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.